-
This Week's Dow Earnings: High Expectations For DuPont And Visa
Sunday, October 23, 2016 - 12:29pm | 747Read More...More than a third of the Dow Jones Industrials are on deck to report quarterly results this week. Wall Street expectations are perhaps highest for a chemicals giant and a leading credit services company. However, just one of these two is expected to show growth on the top line. The third-quarter...
-
This Week's Dow Earnings: Low Expectations For Exxon And Chevron
Sunday, October 23, 2016 - 12:29pm | 643Read More...More than a third of the Dow Jones Industrials are on deck to report quarterly results this week. Wall Street expectations are particularly low for two supermajor oil companies. Just one of these two companies beat earnings estimates in the previous quarter. The third-quarter earnings reporting...
-
FDA Votes In Favor Of Removing Side-Effect Warning On Pfizer's Chantix
Thursday, September 15, 2016 - 8:57am | 444Read More...Pfizer Inc. (NYSE: PFE)'s Chantix is a prescription medication that helps adults 18 years and older quit smoking. The drug has been linked with reports of mental health problems, risk of suicide, depression and death in users, which prompted the U.S. Food and Drug Administration (FDA) to issue...
-
Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?
Wednesday, August 24, 2016 - 2:42pm | 497Read More...Pfizer Inc. (NYSE: PFE) isn't showing any signs of slowing down with its M&A plans. Just days after announcing it will acquire Medivation Inc (NASDAQ: MDVN) for $14 billion, Pfizer said on Wednesday it will pay $1.5 billion to acquire AstraZeneca plc (ADR) (NYSE: AZN)'s late-stage small...
-
Pfizer Has Had A Busy M&A Year...Or Has It?
Tuesday, August 23, 2016 - 8:58am | 435Read More...Pfizer Inc. (NYSE: PFE)'s acquisition of Medivation Inc (NASDAQ: MDVN) may have come as a surprise to some, but Pfizer has a long standing history of pursuing large scale M&A deals. With 2016 more than half over, Pfizer has already dished out $5.2 billion to acquire Anacor and $14 billion this...
-
Merck And Pfizer Earnings: Will They Beat Expectations Again?
Sunday, May 1, 2016 - 11:25am | 601Read More...Among the earnings highlights for the week will be the reports from two major pharmaceutical companies. Wall Street analysts are looking for earnings growth from only one of them. Both companies have exceeded earnings estimates in recent quarters. The earnings season rolls on even as...
-
Facebook And Amazon: More Earnings From The FANG Stocks
Sunday, April 24, 2016 - 4:38pm | 741Read More...Two of the so-called FANG stocks offered up disappointing quarterly results last week. The other two FANG stocks are on deck to share their latest results this week. Wall Street analysts continue to look for strong earnings growth from both of them. The so-called FANG stocks were the momentum...
-
Chrysler And Ford Earnings: Following In GM's Footsteps?
Sunday, April 24, 2016 - 4:38pm | 725Read More...Upcoming earnings highlights include the latest results from two automaker giants. Wall Street analysts are looking for strong earnings growth from both of them. However, estimates have been slipping for one and rising for the other. Expectations were already high for the latest earnings from...
-
Barron's Picks And Pans: Ford, Intel, Sealed Air And More
Sunday, April 17, 2016 - 6:47pm | 670Read More...Featured stories this weekend in Barron's ponder the prospects for a Detroit automaker, a semiconductor giant and the inventor of Bubble Wrap. This issue also has a look at a jet propulsion company and a pair of small cap banks. Other articles discuss the state of the U.S. auto industry, the top...
-
IBM Teams Up With Pfizer To Move Towards Parkinson's Cure
Thursday, April 7, 2016 - 1:47pm | 336Read More...International Business Machines Corp. (NYSE: IBM) and Pfizer Inc. (NYSE: PFE) announced on Thursday a collaboration to develop monitoring solutions aimed at transforming how health care providers deliver care to patients suffering from Parkinson's disease. According to IBM's press...
-
Pfizer Receives FDA Approval For Cheaper Version Of Johnson & Johnson's Top Drug Remicade
Wednesday, April 6, 2016 - 10:45am | 327Read More...Pfizer Inc. (NYSE: PFE) announced after Tuesday's market close that the U.S. Food and Drug Administration approved INFLECTRA, the first and only biosimilar monoclonal antibody therapy, and only the second biosimilar to be approved in the US. INFLECTRA is a treatment indicated for reducing...
-
Here's Chardan's 'Conviction Sell' On Axovant
Wednesday, February 3, 2016 - 1:58pm | 479Read More...According to a note out Wednesday, Chardan Capital Markets has a conviction sell rating on Axovant Sciences Ltd (NYSE: AXON). Citing concerns of overpricing RVT-101 following Axovant's IPO, mixed biopharma data in-lab and consensus estimates as "implausibly high," the firm has a...
-
Pfizer Reports Better-Than-Expected Q4, Shares Dip Lower
Tuesday, February 2, 2016 - 8:23am | 229Read More...Shares of Pfizer Inc. (NYSE: PFE) were trading lower by around 0.5 percent early Tuesday morning after the company reported its fourth quarter results. Pfizer earned $0.53 per share in the fourth quarter on revenue of $14.05 billion. Wall Street analysts were expecting the company to earn $0.52...
-
Google, Yahoo And LinkedIn: Who Can Beat Earnings Expectations?
Sunday, January 31, 2016 - 8:41pm | 640Read More...Three Internet giants are on deck to share their latest earnings results this week. Analysts are looking for strong earnings growth from Google-parent Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) and LinkedIn Corp (NYSE: LNKD). Expectations for Yahoo! Inc. (NASDAQ: YHOO) are considerably more...
-
Pfizer Announces Acquisition Of Top Chinese Healthcare Brand, Considering Sale Of Hospira Pump Unit
Thursday, January 14, 2016 - 11:10am | 201Read More...Pfizer Inc. (NYSE: PFE) announced on Wednesday that it has acquired Sirio Pharma Co's wholly-owned subsidiary, Treerly Health Co. Treerly is a top healthcare brand in China's retail channel. As part of the deal, Pfizer has acquired the entire family of Treerly products which are "...











